Medical Marijuana, Inc. Subsidiary HempMeds® Announces Partnership with First Female UFC Fighter Liz Carmouche

SAN DIEGO, Jan. 24, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Liz Carmouche, the American MMA fighter who competed in the first-ever women’s UFC fight, has become a spokesperson for subsidiary HempMeds® to spread awareness on the benefits of cannabidiol (CBD) for athletes and those looking to lead a healthy, active lifestyle.

Support for cannabis in the professional sports industry is on the rise. CNN recently published that 69% of U.S. citizens are in favor of athletes using cannabis for pain relief purposes and 67% of Americans say using a doctor’s prescription for an opioid painkiller poses a greater health risk than using medical marijuana.

“We’re thrilled to have Ms. Carmouche share how our CBD hemp oil helps her stay on top of her game as a trainer, athlete and small business owner,” said HempMeds® President Stephen Jones. “She has an incredible story and an incredible heart – we’re proud to have her working with us.”

Carmouche, a U.S. Marine Corp Veteran, is the UFC’s most decorated ex-military athlete and is the first openly gay UFC fighter. Nicknamed the “Girl-rilla,” Carmouche is currently the No. 6 ranked 125-pound female MMA fighter in the world, according to the Unified Women’s MMA Rankings.

Now a spokesperson for HempMeds®, Carmouche uses Real Scientific Hemp Oil™ (RSHO™) to train harder and recover faster. Like most athletes, Carmouche was interested and excited to see the news that the World Anti-Doping Agency removed CBD from its 2018 banned substances list, opening up access to thousands to athletes around the globe who are subject to drug tests.

HempMeds® was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 — and the first to both make CBD products available in bulk for U.S. consumers and also provide high-quality CBD hemp oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay.

“I’m excited to share my experience of taking Real Scientific Hemp Oil and hopefully help other people, especially athletes, discover this natural compound that is not only safe to use during intense physical activities, but is non-addictive and won’t get you high,” Carmouche said. “There’s just a lot of misinformation out there and I’d love to help clear that up.”

About HempMeds®

HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]